Faricimab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 619 publications
Intravitreal Anti-VEGF Injection Transitions Across Bevacizumab, Biosimilar, and Branded Medications: The IRIS Registry Study.
Journal: Journal of vitreoretinal diseases
Published: June 23, 2026
Evaluation of Structural and Functional Outcomes After the Application of an Initial Single Dose of Faricimab.
Journal: Journal of vitreoretinal diseases
Published: June 22, 2026
Two-Hit Mechanism of a Massive Retinal Pigment Epithelium Tear in Hypertensive Choroidopathy Superimposed on Chronic Central Serous Chorioretinopathy.
Journal: Journal of vitreoretinal diseases
Published: June 04, 2026
Comparison of Intraocular Inflammation Associated with High-Dose Intravitreal Anti-Vascular Endothelial Growth Factor Agents: A Real-World Disproportionality Analysis.
Journal: Ocular immunology and inflammation
Published: June 01, 2026
Bilateral Occlusive Retinal Vasculitis After Faricimab Rechallenge.
Journal: JAMA ophthalmology
Published: May 28, 2026
Faricimab for choroidal neovascular membrane secondary to choroidal osteoma: A case report.
Journal: The Journal of international medical research
Published: May 14, 2026
Pigment Epithelium-Derived Factor From Müller Cells Is Involved in Angiopoietin-Mediated Survival Control of Retinal Neurons.
Journal: Investigative ophthalmology & visual science
Published: May 11, 2026
Six-Month Real-World Data in Macular Edema Due to Retinal Vein Occlusion Treated with Faricimab: Swiss Retina Research Network Report.
Journal: Ophthalmology and therapy
Published: May 04, 2026
Intravitreal faricimab in type I retinopathy of prematurity: Probably the first case?
Journal: Indian journal of ophthalmology
Published: April 29, 2026
Hypertensive Anterior Uveitis Following Intravitreal Faricimab.
Journal: Ocular immunology and inflammation
Published: April 16, 2026
Last Updated: 06/30/2026